Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hingorani

Showing results (61-70 of 119) with videos related to

Pageof 12
Sort By:
Kidney Medicine|May 27, 2022
Psychiatric Diagnoses in Children With CKD Compared to the General PopulationJessica L Stahl, Aaron G Wightman, Jennifer E Flythe, et al.
Cancer Cell|March 24, 2012
Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinomaPaolo P Provenzano, Carlos Cuevas, Amy E Chang, et al.
Research Square|September 18, 2023
Tumor Response to Stroma-Modifying Therapy: Magnetic Resonance Imaging Findings in Early-Phase Clinical Trials of Pegvorhyaluronidase alpha (PEGPH20)Andrés M Arias-Lorza, James R Costello, Sunil R Hingorani, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 1998
Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivoT S Zheng, S F Schlosser, T Dao, et al.
Journal of Cardiothoracic Surgery|January 3, 2024
Randomized controlled trial of remote ischemic preconditioning in children having cardiac surgeryYuk M Law, Christine Hsu, Sangeeta R Hingorani, et al.
Scientific Reports|May 21, 2024
Magnetic resonance imaging of tumor response to stroma-modifying pegvorhyaluronidase alpha (PEGPH20) therapy in early-phase clinical trialsAndrés M Arias-Lorza, James R Costello, Sunil R Hingorani, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 5, 2023
Association Between Urinary Biomarkers and CKD in Extremely Low Gestational Age NeonatesSangeeta R Hingorani, Robert H Schmicker, Brian Halloran, et al.
The Science of the Total Environment|January 8, 2021
Challenges in quantification of photocatalytic NO<sub>2</sub> abatement effectiveness under real world exposure conditions illustrated by a case studyJ M Cordero, R Hingorani, E Jimenez-Relinque, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
Cross-species antibody microarray interrogation identifies a 3-protein panel of plasma biomarkers for early diagnosis of pancreas cancerJustin E Mirus, Yuzheng Zhang, Christopher I Li, et al.
Gut|February 22, 2014
Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunityIngunn M Stromnes, J Scott Brockenbrough, Kamel Izeradjene, et al.
Pageof 12

Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
Kidney Medicine|May 27, 2022
Psychiatric Diagnoses in Children With CKD Compared to the General PopulationJessica L Stahl, Aaron G Wightman, Jennifer E Flythe, et al.
Cancer Cell|March 24, 2012
Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinomaPaolo P Provenzano, Carlos Cuevas, Amy E Chang, et al.
Research Square|September 18, 2023
Tumor Response to Stroma-Modifying Therapy: Magnetic Resonance Imaging Findings in Early-Phase Clinical Trials of Pegvorhyaluronidase alpha (PEGPH20)Andrés M Arias-Lorza, James R Costello, Sunil R Hingorani, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 1998
Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivoT S Zheng, S F Schlosser, T Dao, et al.
Journal of Cardiothoracic Surgery|January 3, 2024
Randomized controlled trial of remote ischemic preconditioning in children having cardiac surgeryYuk M Law, Christine Hsu, Sangeeta R Hingorani, et al.
Scientific Reports|May 21, 2024
Magnetic resonance imaging of tumor response to stroma-modifying pegvorhyaluronidase alpha (PEGPH20) therapy in early-phase clinical trialsAndrés M Arias-Lorza, James R Costello, Sunil R Hingorani, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 5, 2023
Association Between Urinary Biomarkers and CKD in Extremely Low Gestational Age NeonatesSangeeta R Hingorani, Robert H Schmicker, Brian Halloran, et al.
The Science of the Total Environment|January 8, 2021
Challenges in quantification of photocatalytic NO<sub>2</sub> abatement effectiveness under real world exposure conditions illustrated by a case studyJ M Cordero, R Hingorani, E Jimenez-Relinque, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
Cross-species antibody microarray interrogation identifies a 3-protein panel of plasma biomarkers for early diagnosis of pancreas cancerJustin E Mirus, Yuzheng Zhang, Christopher I Li, et al.
Gut|February 22, 2014
Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunityIngunn M Stromnes, J Scott Brockenbrough, Kamel Izeradjene, et al.
Pageof 12